Status:
COMPLETED
Treatment of Newly Diagnosed Ovarian Cancer With Antioxidants
Lead Sponsor:
Jeanne Drisko, MD, CNS, FACN
Collaborating Sponsors:
Cancer Treatment Research Foundation
University of Kansas Medical Center
Conditions:
Ovarian Cancer
Eligibility:
FEMALE
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
The purpose of this study is to try and understand if there is added benefit or increased harm when antioxidant nutritional supplements are added to traditional chemotherapy in the treatment of ovaria...
Detailed Description
The subjects are randomized to 2 study groups. Group 1 receives standard chemotherapy prescribed by the cancer doctor (carboplatin and paclitaxel)with a possible choice to extend chemotherapy for up t...
Eligibility Criteria
Inclusion
- histologically confirmed carcinoma of the ovary stage III or IV
- measurable or assessable disease
- drug refractory ovarian cancer
- must be 18 years of age or must have parental consent to enroll in the study
- must be ambulatory
Exclusion
- evidence of significant psychiatric disorder by history or exam
- consumption of excess alcohol (more than 4 of any of the following per day: 30 ml distilled spirits, 340 ml beer, or 120 ml wine) or recreational drugs
- tobacco use
- prior treatment with an investigational drug, chemo, radiation therapy, or hormonal therapy within the preceeding month
- pregnancy
Key Trial Info
Start Date :
October 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2007
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT00228319
Start Date
October 1 2002
End Date
August 1 2007
Last Update
June 19 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160